Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase Medical Device Investing
Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st, 2023 Medical Device Investing
Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness Medical Device Investing
Medtronic Designated as a "3+" Company in the 50/50 Women on Boards Gender Diversity Directory Medical Device Investing
BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share Pharmaceutical Investing
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays to Aid in the Risk Assessment of Preeclampsia Medical Device Investing
Jamieson Wellness Inc. Announces Voting Results from 2023 Annual and Special Meeting of Shareholders Life Science Investing
New Clinical Study Suggests the Use of OraPharma's ARESTIN Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis Pharmaceutical Investing
